057680 — T Scientific Co Balance Sheet
0.000.00%
- KR₩62bn
- KR₩66bn
- KR₩43bn
Annual balance sheet for T Scientific Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 14,581 | 15,250 | 30,099 | 9,484 | 3,082 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 8,956 | 8,378 | 6,174 | 14,268 | 12,583 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 28,840 | 30,898 | 45,728 | 31,037 | 22,563 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 620 | 518 | 2,342 | 1,513 | 2,183 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 108,716 | 296,285 | 262,538 | 173,981 | 163,268 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 15,775 | 32,136 | 45,017 | 40,735 | 22,729 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 25,015 | 74,393 | 84,567 | 42,752 | 22,950 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
ESOP Debt Guarantee | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 83,702 | 221,893 | 177,972 | 131,229 | 140,318 |
Total Liabilities & Shareholders' Equity | 108,716 | 296,285 | 262,538 | 173,981 | 163,268 |
Total Common Shares Outstanding |